In a significant move toward enhancing women’s healthcare, the government has announced comprehensive coverage for ‘Endometriosis’ and ‘Polycystic Ovary Syndrome (PCOS)’ treatments under the universal healthcare insurance scheme, Aasandha. The decision, approved following deliberations on a proposal by the Ministry of Social and Family Development, aims to address challenges faced by women seeking treatment for these conditions.
During a press conference, Mohamed Firuzul, Under Secretary for Public Policy at the President’s Office, highlighted the substantial number of women seeking treatment for endometriosis and PCOS. He emphasized that their primary challenge lies in not receiving full Aasandha coverage, leading to the decision to provide comprehensive coverage for these treatments. Firuzul noted that this initiative aligns with the government’s broader goal of facilitating easier access to fertility treatment and in vitro fertilisation (IVF).
Responding to queries about the impact on the budget, Firuzul stated that USD 195 million would be allocated for medical treatment this year. Acknowledging public concerns about limited Aasandha coverage, he reiterated the President’s commitment to expanding coverage and emphasized ongoing efforts to improve management, aiming to reduce the overall cost of Aasandha.
The decision not only addresses existing coverage gaps but also aims to control costs associated with bulk medicine procurement for treating endometriosis and PCOS. While Aasandha already covers treatments for these conditions, the recent decision ensures that patients are not denied coverage based on diagnostic links, particularly cases where infertility has been diagnosed.
To facilitate the decision’s implementation, the government plans to conduct a sensitization program, raising awareness among healthcare professionals. This initiative will contribute to refining treatment protocols in government hospitals and ensuring that women receive the necessary care and support for endometriosis and PCOS.